Indefinite Delivery Contract SPE2DX25D8022

Award Date 7/1/25
Last Date to Order 3/6/35
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award SPE2DU25D8011 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to Cardinal Health, Inc. for pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), U.S. Coast Guard, and U.S. Naval Fleet. The contract has a 30-month base period and three 30-month option periods, with a total estimated value of $4,999,999.00. It is an unrestricted, fully competitive...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Cardinal Health, Inc. as the prime contractor. The IDC, valued at $4,999,999.00, is for the provision of pharmaceutical, medical, and radiopharmaceutical products to support the Department of Defense (DoD), United States Coast Guard, and other government agencies globally. The contract aims to establish a Pharmaceutical Prime...
The federal contract IDV award to Cardinal Health, Inc. is for a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract, valued at up to $999,999,999.00, with the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain as the funding agency. This single-award, indefinite delivery contract is intended to provide worldwide pharmaceutical support, including brand, generic, and specialty pharmaceuticals, to the Department of Defense (DoD), United States Coast Guard,...
The federal contract IDV award to Cardinal Health, Inc. is a single-award Indefinite Delivery Contract (IDC) valued at $76,117,431.74 with a period of performance from March 7, 2025, to March 6, 2035. The contract is with the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain, a defense agency, to provide pharmaceutical (brand, generic, specialty) and pharmaceutical-related products worldwide to the Department of Defense (DoD), United States Coast Guard, and other designated...
The federal contract IDV SPE2DU25D8014 is a single-award Indefinite Delivery Contract awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc. for the provision of pharmaceutical products, including brand, generic, and specialty drugs, to support the Department of Defense (DoD), United States Coast Guard, and other designated federal government customers. The contract has a 30-month base period with three 30-month option periods, for a total estimated value of $4,999,999.00. The...
The federal contract IDV award SPE2DU25D8007 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The contract has a total ceiling value of $4,999,999.00 and a period of performance from July 1, 2025 to March 6, 2036. The contract is part of the DLA Troop Support Medical Supply Chain's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition, which...
The federal contract IDV award is a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The single-award IDV is valued at up to $999,999,999 and has a period of performance from July 1, 2025 to March 6, 2036. The prime contractor is Cardinal Health, Inc., a global healthcare services and products company. The contract aims to establish Prime Vendor Contracts to provide worldwide...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) with a total ceiling value of $4,999,999.00 to Cardinal Health, Inc. for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract. This single-award IDC, with a period of performance from July 1, 2025 to March 6, 2036, aims to establish prime vendor contracts for providing worldwide pharmaceutical support, including brand, generic, and specialty drugs,...
The federal contract IDV award SPE2DX15D0021 was a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The contract, valued at $4,999,999.00, was for the provision of pharmaceutical and medical supplies under the DLA's Pharmaceutical Prime Vendor program. The period of performance ran from December 22, 2014, to June 30, 2025. Cardinal Health, Inc. is a major supplier of...
The federal contract IDV award, SPE2DU25D8010, is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to the prime contractor, Cardinal Health, Inc. The contract provides pharmaceutical, medical, and radiopharmaceutical products and services to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), U.S. Coast Guard, and U.S. Naval Fleet. The IDC has a total ceiling value of...

The federal contract IDV award SPE2DX25D8022 is a single-award Indefinite Delivery Contract held by Cardinal Health, Inc. to provide the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain with pharmaceutical (brand, generic, and specialty) and pharmaceutical-related products worldwide. The contract has a 30-month base period and three 30-month option periods, with a total estimated value of $76,117,431.74.

The original solicitation was for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract, which aims to establish multiple prime vendor contracts to provide pharmaceutical support to the Defense Health Agency, Department of Defense, U.S. Coast Guard, and other government customers. The contract will cover medical pharmaceuticals in the 6505 stock catalog/schedule and the current National Drug Code database, with the intent to make awards to at least three different contractors across regional line items to increase resiliency. The award to Cardinal Health, Inc. appears to be a specific regional contract focused on providing radiopharmaceutical products to VA healthcare facilities.

Generated 7/1/25, 2:18 PM